CD8A and COVID-19: While only 9.5% of the CD8+ T cells from COVID-19 patients were positive for the MIF receptor CD74 on the day of hospital admission, the population of CD74-expressing CD8+ T cells increased to a mean of 49.5% on day 7 (Figure 6E).